Erratum to: Expression and distribution of ‘high affinity’ glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system (Journal of Anatomy, (2008), 10.1111/j.1469-7580.2008.00984.x);Expression and distribution of 'high affinity'glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system

Journal of Anatomy

Volumn 213, Issue 5, 2008, Pages 539-546

  Carozzi, Valentina Alda ^a   Canta, Annalisa ^a   Oggioni, Norberto ^a   Ceresa, Cecilia ^a   Marmiroli, Paola ^a   Konvalinka, Jan ^b   Zoia, Chiara ^a   Bossi, Mario ^a   Ferrarese, Carlo ^a   Tredici, Giovanni ^a   Cavaletti, Guido ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Glutamate; Glutamate transporters; Immunoblotting; Immunohistochemistry; Peripheral nervous system

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE CARBOXYPEPTIDASE II; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MYELINATED NERVE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SATELLITE CELL; SCHWANN CELL; SCIATIC NERVE; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION; WISTAR RAT;

MAMMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 55449122326     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/joa.13841     Document Type: Erratum

References (42)

1. Aoki M, Lin CL, Rothstein JD, et al. (1998) Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann Neurol 43, 645-653.
2. Bacich DJ, Wozniak KM, May Lu XC, et al. (2005) Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury. J Neurochem 95, 314-323.
3. Banner SJ, Fray AE, Ince PG, Steward M, Cookson MR, Shaw PJ (2002) The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neuron disease: An immunohistochemical study. Neuroscience 109, 27-44.
4. Bařinka C, MlčochováP, Šácha P, et al. (2004) Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding. Eur J Biochem 271 (13), 2782-2790.
5. Berger UV, Hediger MA (2000) Distribution of the glutamate transporters GLAST and GLT-1 in rat circumventricular organs, meninges, and dorsal root ganglia. J Comp Neurol 421, 385-399.
6. Berger UV, Luthi-Carter R, Passani LA, et al. (1999) Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415, 52-64.
7. Brumovsky P, Watanabe M, Hökfelt T (2007) Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury. Neuroscience 147, 469-490.
8. Carlton SM (2001) Peripheral excitatory amino acids. Curr Opin Pharmacol 1, 52-56.
9. Carpenter KJ, Sen S, Matthews EA, et al. (2003) Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: An electrophysiological study in the rat. Neuropeptides 37, 298-306.
10. Choi I, Chiu SY (1997) Expression of high affinity neuronal and glial glutamate transporters in rat optic nerve. Glia 20, 184-192.
11. Cvrcek P. (2008) Side effects of ketamine in the long-term treatment of neuropathic pain. Pain 9, 253-257.
12. De Biasi S, Rustioni A (1988) Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 85, 7820-7824.
13. Dickenson AH (1997) NMDA receptor antagonists: Interactions with opioids. Acta Anaesthesiol Scand 41, 112-115.
14. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channel. Pharmacol Rev 51, 7-61.
15. Fisher K, Lefebvre C, Coderre TJ (2002) Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Pharmacol Biochem Behav 73, 411-418.
16. Garry EM, Jones E, Fleetwood-Walker SM (2004) Nociception in vertebrates: Key receptors participating in spinal mechanisms of chronic pain in animals. Brain Res Brain Res Rev 46, 216-224.
17. Ghadge GD, Slusher BS, Bodner A, et al. (2003) Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc Natl Acad Sci USA 100(16), 9554-9559.
18. Huettner JE, Kerchner GA, Zhuo M (2002) Glutamate and the presynaptic control of spinal sensory transmission. Neuroscientist 8, 89-92.
19. Kawamata M, Omote K (1996) Involvement of increased excitatory amino acids and intracellular calcium concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain 68, 85-96.
20. Keast JR, Stephensen TM (2000) Glutamate and aspartate immunoreactivity in dorsal root ganglion cells supplying visceral and somatic targets and evidence for peripheral axonal transport. J Comp Neurol 424, 577-587.
21. Kugler P, Beyer A (2003) Expression of Glutamate transporters in human and rat retina and rat optic nerve. Histochem Cell 120, 199-212.
22. Labrande C, Velly L, Canolle B, et al. (2006) Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: Role of glutamate uptake and FK506 binding protein 12.kDa. Neuroscience 137, 231-239.
23. Miller H, Levey AI, Rothstein JD, Tzingounis AV, Conn PJ (1997) Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J Neurochem 68, 1564-1570.
24. Ohgoh M, Hanada T, Smith T, et al. (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 125, 170-178.
25. Oliveira AL, Hydling F, Olsson E, et al. (2003) Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia. Synapse 50, 117-129.
26. Olszewski RT, Buchari N, Zhou J (2004) NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J Neurochem 89, 876-885.
27. Otori Y, Shimada S, Tanaka K, Ishimoto I, Tano Y, Tohyama M (1994) Marked increase in glutamate-aspartate transporter (GLAST/GluT-1) mRNA following transient retina ischemia. Brain Res Mol Brain Res 27, 310-314.
28. Ozawa S, Kamiya H, Tsuzuki K (1998) Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54, 581-618.
29. Rinholm JE, Slettaløkken G, Marcaggi P, et al. (2007) Subcellular localization of the glutamate transporters GLAST and GLT at the neuromuscular junction in rodents. Neuroscience 16, 579-591.
30. Slusher BS, Vornov JJ, Thomas AG (1999) Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 5, 1396-1402.
31. Sung B, Lim G, Mao J (2003) Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23, 2899-2910.
32. Tao F, Liaw WJ, Zhang B (2004) Evidence of neuronal excitatory amino acid carrier 1 expression in rat dorsal root ganglion neurons and their central terminals. Neuroscience 123, 1045-1051.
33. Van der Post JP, de Visser SJ, de Kam ML, et al. (2005) The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. Br J Clin Pharmacol 2, 128-136.
34. Watkins JC (2000) L-glutamate as a central neurotransmitter: Looking back. Biochem Soc Trans 28, 297-309.
35. Westlund KN, McNeill DL, Coggeshall RE (1989) Glutamate immunoreactivity in rat dorsal root axons. Neurosci Lett 96, 13-17.
36. Willis WDJ, Coggeshall RE (2004) Sensory Mechanisms of the Spinal Cord, 3rd edn. New York: Plenum.
37. Yamamoto T, Nozalis-Tagushi N, Sakashita Y (2001) Inhibition of spinal N-acetylated-alpha-linked acidic dipeptidase produces an antinociceptive effect in the rat formalin test. Neuroscience 102, 473-479.
38. Yamamoto T, Hirasawa S, Wroblewska B (2004) Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci 20, 483-494.
39. Yashpal K, Fisher K, Chabot JG, Coderre TJ (2001) Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Pain 94, 17-29.
40. Yoshimura M, Jessell T (1990) Amino acid-mediated EPSPs at primary afferent synapses with substantia gelatinosa neurones in the rat spinal cord. J Physiol 430, 315-335.
41. Zhang W, Murakawa Y, Wozniak KM, Slusher BS, Sima AA (2006) The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy. J Neurol Sci 247, 217-223.
42. Zhang W, Slusher BS, Murakawa Y, et al. (2002) GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/ Wor rats. J Neurol Sci 194, 21-28.